LakeShore Biopharma Co (LakeShore Biopharma Co) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of Sep. 2023)

View and export this data going back to 2023. Start your Free Trial

What is LakeShore Biopharma Co Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

LakeShore Biopharma Co's net issuance of preferred for the six months ended in Sep. 2023 was $0.00 Mil. The number is 0, which means that LakeShore Biopharma Co has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

LakeShore Biopharma Co's net issuance of preferred for the trailing twelve months (TTM) ended in Sep. 2023 was $0.00 Mil.

LakeShore Biopharma Co Net Issuance of Preferred Stock Historical Data

The historical data trend for LakeShore Biopharma Co's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LakeShore Biopharma Co Net Issuance of Preferred Stock Chart

LakeShore Biopharma Co Annual Data

Trend

Mar21

Mar22

Mar23

Net Issuance of Preferred Stock

112.03

LakeShore Biopharma Co Semi-Annual Data
	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Net Issuance of Preferred Stock	Get a 7-Day Free Trial			-	-	-	-	-

LakeShore Biopharma Co Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

LakeShore Biopharma Co Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of LakeShore Biopharma Co's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

LakeShore Biopharma Co (LakeShore Biopharma Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LakeShore Biopharma Co Ltd (NAS:LSB) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

H6Z:Germany

Address

38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629

Website

https://www.yishengbio.com

YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminium-free lyophilized rabies vaccine that was launched in China. It has one operating segment, which is the development, production, marketing and sale of biopharmaceutical products.